Holen Sie sich die Stockscreener-App
11.03
1.85%
0.20
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result - GuruFocus.com
Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years - Yahoo Finance
Liquidia (LQDA) to Release Quarterly Earnings on Monday - MarketBeat
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024 - Yahoo Finance
Liquidia Corp's chief business officer sells shares worth $5,190 - Investing.com India
Liquidia Corp's chief business officer sells shares worth $5,190 By Investing.com - Investing.com Australia
Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Analysts Set Liquidia Co. (NASDAQ:LQDA) PT at $24.67 - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - PR Newswire
Liquidia CEO Roger Jeffs sells $89,450 in stock By Investing.com - Investing.com South Africa
Liquidia's chief business officer sells $12,729 in stock By Investing.com - Investing.com South Africa
Liquidia's chief commercial officer sells $16,961 in stock By Investing.com - Investing.com South Africa
Liquidia's chief business officer sells $12,729 in stock - Investing.com India
Liquidia's chief commercial officer sells $16,961 in stock - Investing.com India
Liquidia corp CFO Michael Kaseta sells $43,231 in stock - Investing.com India
Liquidia corp CFO Michael Kaseta sells $43,231 in stock By Investing.com - Investing.com Australia
Liquidia Corp (LQDA) rating upgrades by Raymond James - Knox Daily
Liquidia's general counsel Russell Schundler sells shares worth $28,613 By Investing.com - Investing.com Australia
Liquidia's chief medical officer sells $25,103 in stock By Investing.com - Investing.com Canada
Liquidia's general counsel Russell Schundler sells shares worth $28,613 - Investing.com India
Liquidia's chief medical officer sells $25,103 in stock - Investing.com India
Russell Schundler Sells 2,576 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia CEO Roger Jeffs sells $89,450 in stock - Investing.com
Daily Market Movement: Liquidia Corp (LQDA) Sees a 0.45 Increase, Closing at 11.14 - The Dwinnex
A year in review: Liquidia Corp (LQDA)’s performance in the last year - US Post News
Check out these key findings about Liquidia Corp (LQDA) - SETE News
Liquidia Corp [LQDA] Shares Fall -0.54 % on Thursday - Knox Daily
Financial Metrics Check: Liquidia Corp (LQDA)’s Ratios for Trailing Twelve Months - The Dwinnex
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ... - Yahoo Finance
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigatin - GuruFocus.com
Liquidia Corp (LQDA) shows promising results - US Post News
Liquidia shares keep strong buy rating as Supreme Court denies UTHR patent appeal - Investing.com
LQDA (Liquidia Corp) may reap gains as insiders became active recently - Knox Daily
Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains? - Yahoo Finance
Liquidia shares jump 11% on court ruling - The Pharma Letter
Liquidia Corp (LQDA) Performance and Fundamentals Dashboard tells a completely different story - SETE News
BTIG maintains Buy rating on Liquidia with $25 target - Investing.com
Liquidia Corp (LQDA) Stock: A Year of Market Fluctuations - The InvestChronicle
Liquidia (NASDAQ:LQDA) Sees Strong Trading VolumeWhat's Next? - MarketBeat
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent - GlobeNewswire Inc.
Liquidia jumps as Supreme Court rejects United Therapeutics request for appeal in Tyvaso patent dispute - Seeking Alpha
Lifesci Capital Weighs in on Liquidia Co.'s Q3 2024 Earnings (NASDAQ:LQDA) - MarketBeat
Liquidia Corporation - The Pharma Letter
Liquidia Corp [NASDAQ: LQDA] Sees Increase in Stock Value - Knox Daily
Liquidia (NASDAQ:LQDA) Upgraded at Lifesci Capital - MarketBeat
Liquidia Technologies shares maintain Outperform rating from LifeSci Capital - Investing.com
Evaluating Liquidia: Insights From 14 Financial Analysts - Benzinga
Liquidia (NASDAQ:LQDA) Now Covered by Analysts at Lifesci Capital - MarketBeat
Liquidia Technologies shares maintain Outperform rating from LifeSci Capital By Investing.com - Investing.com UK
Results from Liquidia Corp (LQDA) show risk - US Post News
Liquidia and Pharmosa announce biobucks partnership to develop L606 - The Pharma Letter
Liquidia Co. (NASDAQ:LQDA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Liquidia Co. (NASDAQ:LQDA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
1.47%
6.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):